P

Inventor

GLEASON JOHN G

US45 patents
⚠️ This page may combine multiple inventors who share the name “GLEASON JOHN G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE CORP

19 patents
US4200572AApr 29, 1980

Substituted azetidinones

SMITHKLINE CORP14 citations74
US4166816ASep 4, 1979

Methods and intermediates for preparing cis-4-oxoazetidine intermediates

SMITHKLINE CORP10 citations74
US4350685ASep 21, 1982

Antiallergic imidodisulfamides

SMITHKLINE CORP12 citations67
US4350698ASep 21, 1982

Antiallergic imidosulfamides

SMITHKLINE CORP4 citations63
US4317826AMar 2, 1982

N,N'-Bis[substituted-1,2,3,4 tetrahydroisoquinolyl]disulfonylimides and antiallergic compositions and method of use

SMITHKLINE CORP5 citations63
US4236001ANov 25, 1980

7β-Acyloxy-3-heterocyclicthiomethyl cephalosporins

SMITHKLINE CORP3 citations63
US4158733AJun 19, 1979

7β-Acyloxy-3-acetoxymethyl cephalosporins

SMITHKLINE CORP1 citations63
US4103086AJul 25, 1978

8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives

SMITHKLINE CORP2 citations63
US4020057AApr 26, 1977

7β-Acyloxy cephalosporins

SMITHKLINE CORP3 citations63
US4000154ADec 28, 1976

3-Substituted-6β-(amino- and acylamino)-7-oxo-1,3-diazabicyclo[3.2.0]-h

SMITHKLINE CORP6 citations63
US4108854AAug 22, 1978

Process for preparing substituted glycines

SMITHKLINE CORP5 citations62
US3997584ADec 14, 1976

Substituted glycines and intermediates thereof

SMITHKLINE CORP2 citations62
US3994954ANov 30, 1976

Process for preparing substituted glycines

SMITHKLINE CORP4 citations62
US4257947AMar 24, 1981

3-Amino-2-hydroxy, halo or mercaptomethyl-4-oxoazetidines

SMITHKLINE CORP1 citations52
US4218564AAug 19, 1980

7β-Hydroxy-3-heterocyclicthio-methyl cephalosporin intermediates

SMITHKLINE CORP1 citations52
US4131734ADec 26, 1978

7β-Acyloxy-3-heterocyclicthiomethyl cephalosporins

SMITHKLINE CORP0 citations52
US4187375AFeb 5, 1980

Process for preparing oxazine ring compounds

SMITHKLINE CORP1 citations51
US4162250AJul 24, 1979

3-Aminoazetidinone derivatives

SMITHKLINE CORP0 citations51
US3963733AJun 15, 1976

3-(P-methoxybenzylthio)2-non-oxocarbonylic pyridines

SMITHKLINE CORP0 citations42

SMITHKLINE BEECHAM CORP

15 patents
US6413952B1Jul 2, 2002

Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal

SMITHKLINE BEECHAM CORP54 citations95
US5444081AAug 22, 1995

Substituted histidines having angiotension II receptor antagonist activity

SMITHKLINE BEECHAM CORP54 citations95
US6280959B1Aug 28, 2001

Metal complexes

SMITHKLINE BEECHAM CORP48 citations92
US5449687ASep 12, 1995

4-phenyl-1,2-cyclohexyl derivatives and anti-inflammatory compositions and methods thereof

SMITHKLINE BEECHAM CORP31 citations92
US5314918AMay 24, 1994

Leukotriene antagonists

SMITHKLINE BEECHAM CORP7 citations73
US5145858ASep 8, 1992

Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors

SMITHKLINE BEECHAM CORP13 citations72
US5002941AMar 26, 1991

Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors

SMITHKLINE BEECHAM CORP12 citations70
US4996214AFeb 26, 1991

Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof

SMITHKLINE BEECHAM CORP7 citations70
US5134150AJul 28, 1992

Inhibition of the 5-lipoxygenase pathway

SMITHKLINE BEECHAM CORP6 citations59
US4937253AJun 26, 1990

Ester prodrugs

SMITHKLINE BEECHAM CORP6 citations56
US5565480AOct 15, 1996

Substituted histidines

SMITHKLINE BEECHAM CORP0 citations51
US4939279AJul 3, 1990

Leukotriene antagonists

SMITHKLINE BEECHAM CORP1 citations51
US4954513ASep 4, 1990

Leukotriene antagonists

SMITHKLINE BEECHAM CORP1 citations49
US5143931ASep 1, 1992

Leukotriene antagonists containing tetrazolyl groups

SMITHKLINE BEECHAM CORP1 citations47
US5135938AAug 4, 1992

Leukotriene antagonists

SMITHKLINE BEECHAM CORP0 citations36

SMITHKLINE BECKMAN CORP

10 patents

ALDEYRA THERAPEUTICS INC

1 patent